1 Canadian Stock Down 42% to Buy and Hold Forever

This health tech stock is trading at a discount as it continues to grow and expand a business very much in demand.

Key Points
  • Well Health Technologies Corp. (TSX:WELL) is digitizing Canada's healthcare system with the country's largest outpatient clinic network and technology solutions.
  • The company raised 2026 guidance to $1.58-$1.65 billion in revenue and $185-$195 million in adjusted EBITDA following its latest quarter.
  • Despite being down 42% from recent highs and trading below $5, the stock remains a strong long-term buy as the company continues expanding its in-demand healthcare digitization platform.

There are plenty of Canadian stocks that continue to perform well on the TSX. In this article, I’d like to discuss one that has not been performing so well, despite a strong thesis for the underlying business.

Well Health Technologies Corp. (TSX: WELL) has been hard at work digitizing the Canadian healthcare industry. It’s a transformation that’s been sorely needed, and one that’s creating tons of value for doctors and patients alike. So why is Well Health Technologies’ stock price still stuck below $5?

telehealth stocks

Image source: Getty Images

What is this Canadian stock all about?

Well Health is an omnichannel digital healthcare company that has the largest outpatient medical clinic network in Canada. This network consists of primary, specialized, and diagnostic healthcare services and facilities. These facilities use Well Health’s technology solutions to enhance productivity, profitability and patient care.

But Well Health’s offering doesn’t stop there. Even healthcare providers who don’t choose to join Well Health’s clinic network can still purchase its technology solutions. These solutions include electronic medical records (EMR) platforms and services, digital booking, and e-referrals.

In short, Well Health Technologies is modernizing and digitizing the Canadian healthcare system, and the rapid growth of the company is evidence that this is very much in demand.

Well Health financials

This Canadian stock has been rapidly growing for quite a few years now. In fact, the company has had a fantastic five years – consistent double-digit revenue growth and increasing profitability and cash flows. Revenue increased more than 360% to $1.4 billion in 2025. Also, adjusted earnings per share (EPS) was $0.50, up from a mere $0.05 in 2021.

Also, Well Health’s latest quarterly results came in strong once again. Although revenue growth was slower, at 12%, the company closed two acquisitions in the quarter, which will help increase future growth rates. In fact, the business continues to compound and the company was seeing a return of stronger momentum in the back end of the second quarter.

A key takeaway from the quarter is the company raised its revenue and earnings guidance once again. The new 2026 revenue guidance is now between $1.58 billion to $1.65 billion. And the new 2026 adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) guidance is now between $185 million and $195 million.  

A Canadian stock to hold forever

While the recent quarter posted record patient visits and strong additions to its clinic network, the earnings results were not as impressive. In fact, earnings per share (EPS) came in at $0.04, down from $0.10 in the same period last year. This was due to higher interest expense and acquisition costs.

Digitizing the Canadian healthcare system takes time and investment. This is a long process, but Well Health continues to grow and expand as its offering is very much in demand. Looking ahead, I expect Well Health to continue to drive profitability and revenue. While the stock is down 42% from its recent highs, it’s still a strong long-term buy, in my view.

Fool contributor Karen Thomas has positions in Well Health Technologies. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Tech Stocks

a person watches a downward arrow crash through the floor
Dividend Stocks

The TSX Dropped 736 Points Thursday: Here’s Why Long-Term Investors Can Stay Calm

Long-term investors can stay calm in the gyrating waters of the stock market by maintaining portfolio diversification and rebalancing periodically.

Read more »

The virtual button with the letters AI in a circle hovering above a keyboard, about to be clicked by a cursor.
Tech Stocks

OpenText’s Revenue Fell Again, But Here’s What Investors Could Be Missing

OpenText’s latest results reveal growth beneath falling revenue, with its AI opportunity depending on turning customer demand into stronger earnings.

Read more »

running robot changes direction
Tech Stocks

Lightspeed Stock Drops 14% After Earnings: Here’s Why I’d Buy the Dip

Dax Dasilva explains how better customer deals and AI that tackles merchants’ daily chores could strengthen Lightspeed’s recovery.

Read more »

gift is bigger than the other
Tech Stocks

Holiday Test Ahead: Shopify Forecasts Another 30%-Plus Quarter as Shoppers Gear Up

Shopify forecasts another quarter of 30%-plus revenue growth. Here’s what its holiday outlook means for investors, and which results to…

Read more »

businesswoman meets with client to get loan
Tech Stocks

Your TFSA Doesn’t Need Another Speculative Stock: Here’s the Growth Case for CGI

CGI offers a growth case built on paying clients, rising per-share earnings, and a shrinking share count.

Read more »

man studies at computer
Tech Stocks

Here’s What a $10,000 Investment in Anthropic Could Be Worth by 2030

Anthropic could be a huge moneymaker for investors if it can maintain its rapid growth rate.

Read more »

woman considering the future
Tech Stocks

Shopify Stock Fell After Earnings: Here’s How I’d Judge It for a 10-Year TFSA

Shopify's selloff offers a cheaper entry into a growing business, but a 10-year TFSA still needs price discipline.

Read more »

young adult uses credit card to shop online
Tech Stocks

Shopify Stock Tumbles Despite 32% Sales Growth: Buy Now, or Buyer Beware?

Shopify stock fell despite 32% sales growth. Explore what drove the selloff and whether stronger cash flow makes the shares…

Read more »